Dapagliflozin in Pulmonary Arterial Hypertension
NCT05179356
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
52
Enrollment
OTHER
Sponsor class
Conditions
Pulmonary Arterial Hypertension
Chronic Thromboembolic Pulmonary Hypertension
Interventions
DRUG:
Dapagliflozin 10 MG [Farxiga]
DRUG:
Placebo
Sponsor
Mads Ersbøll